EW - Edwards Lifesciences Inc. Annual Revenue Growth (Last Twelve Months)

The sales volume growth rate compared to the same period last year (TTM) for Edwards Lifesciences (EW) demonstrates revenue growth driven by an aging population and physician adherence to transcatheter method training. The value 13.30 reflects the current magnitude of this process. The foundation of success is built upon TAVR valve patents and FDA certifications, as well as close cooperation with leading surgeons during clinical trials.
Edwards Lifesciences Corporation - analytical breakdowns and key metrics (EW)

This indicator measures business expansion rates by comparing total revenue over the last twelve months with the same period last year to assess real scaling dynamics. By analyzing the relative year-over-year revenue growth (12 months), an investor can see the commercial efficiency of Edwards Lifesciences (EW) in implementing minimally invasive heart valves, where increasing levels confirm the market dominance of innovative medical technologies.